Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Andersen

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Novartis Foundation Symposium|March 31, 2001
Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?J K Andersen
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 20, 2001
Does neuronal loss in Parkinson's disease involve programmed cell death?J K Andersen
International Journal of Food Microbiology|December 1, 1988
Contamination of freshly slaughtered pig carcasses with human pathogenic Yersinia enterocoliticaJ K Andersen
Frontiers in Bioscience : a Journal and Virtual Library|March 25, 1998
Use of genetically engineered mice as models for exploring the role of oxidative stress in neurodegenerative diseasesJ K Andersen
Methods in Molecular Medicine|February 22, 2012
The use of genetically engineered mice in aging researchJ K Andersen
Mechanisms of Ageing and Development|September 16, 2000
What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease?J K Andersen
Molecular Biotechnology|November 8, 2001
Genetically engineered mice and their use in aging researchJ K Andersen
Letters in Applied Microbiology|April 4, 2000
Variations in virulence between different electrophoretic types of Listeria monocytogenesB Nørrung, J K Andersen
IUBMB Life|May 4, 2000
The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicityF Yantiri, J K Andersen
Mechanisms of Ageing and Development|August 21, 2001
Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?S Rajagopalan, J K Andersen
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Novartis Foundation Symposium|March 31, 2001
Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?J K Andersen
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 20, 2001
Does neuronal loss in Parkinson's disease involve programmed cell death?J K Andersen
International Journal of Food Microbiology|December 1, 1988
Contamination of freshly slaughtered pig carcasses with human pathogenic Yersinia enterocoliticaJ K Andersen
Frontiers in Bioscience : a Journal and Virtual Library|March 25, 1998
Use of genetically engineered mice as models for exploring the role of oxidative stress in neurodegenerative diseasesJ K Andersen
Methods in Molecular Medicine|February 22, 2012
The use of genetically engineered mice in aging researchJ K Andersen
Mechanisms of Ageing and Development|September 16, 2000
What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease?J K Andersen
Molecular Biotechnology|November 8, 2001
Genetically engineered mice and their use in aging researchJ K Andersen
Letters in Applied Microbiology|April 4, 2000
Variations in virulence between different electrophoretic types of Listeria monocytogenesB Nørrung, J K Andersen
IUBMB Life|May 4, 2000
The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicityF Yantiri, J K Andersen
Mechanisms of Ageing and Development|August 21, 2001
Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?S Rajagopalan, J K Andersen
Pageof 8